With expertise in host-microbial interactions, Aquila Bioscience Ltd. (ABL) has developed a safe, effective and environmentally friendly technology that removes pathogen burden from surfaces including skin and wound. This not only protects people from harmful pathogens but also minimizes the impact of pathogen exposure and prevents secondary contamination
Now more than ever there is a need for safe and non-toxic methods to disable bio-threats including pandemic viruses in our societies. Past flu pandemics, outbreaks of Ebola, SARS and recent Wuhan Coronavirus, as well as other intended and unintended spread of pathogenic organisms and use of biotoxins require safe and effective decontamination strategies to prevent the spread.
Chemical based methods such as sodium hypochloride are the most commonly used methods for the decontamination of critical infrastructure and biological surfaces. However, this can result in damage to the infrastructure, cellular surfaces as well as pose environmental and health hazards. Civilians located in the infected areas during an attack are generally quarantined, washed with water and detergent, and then monitored for onset of symptoms. In cases where pathogens or viruses remain on human skin, water and detergent may not displace or kill the pathogen from the skin and may lead to secondary contamination. This is also important because several pathogens have the ability to transmit before the symptoms of infections appear in infected individuals.
Aquila Bioscience specializes in the science of the attachment between microbes and host cell surfaces. Pathogens such as bacteria and viruses enter human cells by binding to specialized carbohydrates (glycans) and proteins (lectins) on the surface of the cells. Aquila Bioscience uses its technologies and expertise to disrupt these interactions between pathogens and human cells by using the right combination of glycans and lectins against the pathogens.
Our technologies are inspired by nature, completely non-toxic can be used in the form of wipes, towels and masks to protect first-line responders and civilians. It can be safely, effectively and frequently used on skin, open wounds, mucosal surfaces etc without posing hazardous risks to nearby civilians. Aquila Bioscience has been supported by the European Defence Agency and European Union Horizon2020 to develop CBRN decontamination strategies.